TOSI, FEDERICA MARIA
TOSI, FEDERICA MARIA
Dipartimento di Oncologia ed Emato-Oncologia
Ongoing Clinical Trials and Future Research Scenarios of Circulating Tumor DNA for the Treatment of Metastatic Colorectal Cancer
2024 L. Roazzi, G. Patelli, K.B. Bencardino, A. Amatu, E. Bonazzina, F. Tosi, B. Amoruso, A. Bombelli, S. Mariano, S. Stabile, C. Porta, S. Siena, A. Sartore-Bianchi
Clinicopathological characterisation of MTAP alterations in gastrointestinal cancers
2024 G. Mauri, G. Patelli, L. Roazzi, E. Valtorta, A. Amatu, G. Marrapese, E. Bonazzina, F. Tosi, K. Bencardino, G. Ciarlo, E. Mariella, S. Marsoni, A. Bardelli, E. Bonoldi, A. Sartore-Bianchi, S. Siena
Circulating tumor DNA to drive treatment in metastatic colorectal cancer
2023 G. Patelli, G. Mauri, F. Tosi, A. Amatu, K. Bencardino, E. Bonazzina, E.G. Pizzutilo, F. Villa, G. Calvanese, A.G. Agostara, S. Stabile, S. Ghezzi, G. Crisafulli, F. Di Nicolantonio, S. Marsoni, A. Bardelli, S. Siena, A. Sartore-Bianchi
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study
2022 A. Amatu, G. Mauri, F.M. Tosi, K. Bencardino, E. Bonazzina, V. Gori, L. Ruggieri, S. Arena, A. Bardelli, S. Marsoni, S. Siena, A. SARTORE BIANCHI
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
2022 A. Sartore-Bianchi, F. Pietrantonio, S. Lonardi, B. Mussolin, F. Rua, G. Crisafulli, A. Bartolini, E. Fenocchio, A. Amatu, P. Manca, F. Bergamo, F. Tosi, G. Mauri, M. Ambrosini, F. Daniel, V. Torri, A. Vanzulli, D. Regge, G. Cappello, C. Marchiò, E. Berrino, A. Sapino, S. Marsoni, S. Siena, A. Bardelli
Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review
2022 G. Gazzaniga, F. Villa, F. Tosi, E.G. Pizzutilo, S. Colla, S. D'Onghia, G. Di Sanza, G. Fornasier, M. Gringeri, M.V. Lucatelli, G. Mosini, A. Pani, S. Siena, F. Scaglione, A. Sartore-Bianchi
Case Report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer
2022 G. Mauri, G. Patelli, V. Gori, C. Lauricella, B. Mussolin, A. Amatu, K. Bencardino, F. Tosi, E. Bonazzina, E. Bonoldi, A. Bardelli, S. Siena, A. Sartore-Bianchi
The evolving panorama of HER2-targeted treatments in metastatic urothelial cancer: A systematic review and future perspectives
2022 G. Patelli, A. Zeppellini, F. Spina, E. Righetti, S. Stabile, A. Amatu, F. Tosi, S. Ghezzi, S. Siena, A. Sartore-Bianchi
Empowering clinical decision making in oligometastatic colorectal cancer: The potential role of drug screening of patient-derived organoids
2021 G. Mauri, E. Durinikova, A. Amatu, F. Tosi, A. Cassingena, F. Rizzetto, K. Buzo, P. Arcella, M.C. Aquilano, E. Bonoldi, S. Marsoni, S. Siena, A. Bardelli, A. Sartore Bianchi, S. Arena
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature
2021 G. Patelli, K. Bencardino, F. Tosi, M. Pugliano, F. Lanzani, A. Innocenti, A. Rinaldo, G. Mauri, G. Cerea, A. Sartore-Bianchi, M. Torre, E.C. Agostoni, S. Siena
The evolutionary landscape of treatment for BRAFv600e mutant metastatic colorectal cancer
2021 G. Mauri, E. Bonazzina, A. Amatu, F. Tosi, K. Bencardino, V. Gori, D. Massihnia, T. Cipani, F. Spina, S. Ghezzi, S. Siena, A. Sartore Bianchi
Strategies to tackle RAS-mutated metastatic colorectal cancer
2021 G. Patelli, F. Tosi, A. Amatu, G. Mauri, A. Curaba, D.A. Patane, A. Pani, F. Scaglione, S. Siena, A. Sartore Bianchi
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
2021 G. Patelli, C. Vaghi, F. Tosi, G. Mauri, A. Amatu, D. Massihnia, S. Ghezzi, E. Bonazzina, K. Bencardino, G. Cerea, S. Siena, A. Sartore Bianchi
Entrectinib for the treatment of metastatic NSCLC: safety and efficacy
2020 A. Sartore Bianchi, E.G. Pizzutilo, G. Marrapese, F. Tosi, G. Cerea, S. Siena
The quest for improving treatment of cancer of unknown primary (CUP) through molecularly-driven treatments: a systematic review
2020 R. Lombardo, F. Tosi, A. Nocerino, K. Bencardino, V. Gambi, R. Ricotta, F. Spina, S. Siena, A. Sartore Bianchi
Liquid biopsy for rectal cancer: a systematic review
2019 D. Massihnia, E.G. Pizzutilo, A. Amatu, F.M. Tosi, S. Ghezzi, K. Bencardino, P. DI MASI, E. Righetti, G. Patelli, F. Scaglione, A. Vanzulli, S. Siena, A. SARTORE BIANCHI
Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies
2019 G. Mauri, E.G. Pizzutilo, A. Amatu, K. Bencardino, L. Palmeri, E.F. Bonazzina, F. Tosi, G. Carlo Stella, G. Burrafato, F. Scaglione, S. Marsoni, G. Siravegna, A. Bardelli, S. Siena, A. Sartore-Bianchi
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
2019 A. Sartore-Bianchi, A. Amatu, L. Porcu, S. Ghezzi, S. Lonardi, F. Leone, F. Bergamo, E. Fenocchio, E. Martinelli, B. Borelli, F. Tosi, P. Racca, E. Valtorta, E. Bonoldi, C. Martino, C.M.S.L. Vaghi, G. Marrapese, F. Ciardiello, V. Zagonel, A. Bardelli, L. Trusolino, V. Torri, S. Marsoni, S. Siena
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
2019 A. Amatu, M. Schirripa, F. Tosi, S. Lonardi, K. Bencardino, E. Bonazzina, L. Palmeri, D.A. Patanè, E.G. Pizzutilo, B. Mussolin, F. Bergamo, G. Alberti, R. Intini, L. Procaccio, M. Arese, S. Marsoni, M. Nichelatti, V. Zagonel, S. Siena, A. Bardelli, F. Loupakis, F. Di Nicolantonio, A. Sartore-Bianchi, L. Barault
Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer
2019 A. Amatu, A. Sartore-Bianchi, K. Bencardino, E.G. Pizzutilo, F. Tosi, S. Siena